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The production of immune y-interferon (IFN-y) after mitogen stimulation of T cell 
populations is now well established (1, 2). Antigen-specific IFN-y induction has only 
been demonstrated in sensitized animals, or in vitro by lymphocytes obtained from 
these animals after challenge with specific antigen (3-6). Sonnenfeld et al. (6), using 
a panel of serum to define the cell population responsible for antigen-specific IFN-y 
induction, suggested that cytotoxic T lymphocytes in cooperation with B lymphocytes, 
macrophages, or both, produced IFN-y. It was found in subsequent work with anti-T 
cell  monoclonal  reagents  that  OK-T8  antibodies  that  recognized  the  cytotoxic/ 
suppressor cells failed to induce IFN-y (7). However, marginal levels of IFN-y were 
obtained  with  OK-T4  antibodies  that  recognized  the  helper  subpopulation.  The 
cellular interactions required for IFN-y production are thus apparently as complex as 
other immune responses and could be more easily studied with T  cell lines. 
We investigated the ability of antigen to induce IFN-y in two continuous T  cell 
lines that have been shown to mediate hapten-specific delayed hypersensitivity (DTH) 
to  the contact  sensitizing agent,  oxazolone,  a Both  cell  lines produced  IFN-y after 
stimulation by specific antigen. The IFN-y induction was restricted by the I region of 
the MHC. The simplicity and reproducibility of this assay system will provide us 
with considerable potential for testing T  lymphocyte function at the clonal level. 
Materials and Methods 
Mice.  6-8-wk-old BALB/c, CBA,  (CBA  ×  BALB/c)FI, BALB/c (H-2k), and A.TL mice 
were obtained from The Walter and Eliza Hall Institute of Medical Research. 
Preparation of Antigen-presenting Cells (APC).  The 4-ethoxmethylene-2-phenyl  oxazolone (ox- 
azolone) and picryl chloride (BDH Chemicals, Ltd., Poole, United Kingdom) were dissolved in 
ethanol at concentrations of 3% and 5%, respectively.  A total of 100/~1 of antigen solution was 
painted on  the clipped thorax,  abdomen, and forepaws  of mice.  The following day a  cell 
suspension was prepared from the inguinal, subcapsular, and axillary lymph nodes, in Hepes- 
(i0 mM, Sigma Chemical Company, St. Louis, MO) buffered Eagle's medium (Flow Labora- 
tories,  Stanmore, Australia). Cells were washed  and irradiated  (2,000  rad  at  900  rad/min, 
Phillips RT250 x-ray machine). Cells were washed again and added to the lymphocyte cultures. 
Cells and Culture ,~tedia.  Lymphocytes were cultured in RPMI  1640 (Flow  Laboratories) 
containing 5  ×  10  -5  M  2-mercaptoethanol (Calbiochem-Behring Corp;  American Hoechst 
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Corp.,  La Jolla,  CA),  2  mM  L-glutamine  (Commonwealth  Serum  Laboratories,  Parkville, 
Australia),  and  10%  heat-inactivated  fetal  calf serum  (Flow  Laboratories).  For  long-term 
cultures, this was supplemented with supernatant from concanavalin A-stimulated spleen cell 
cultures (CAS) as described in detail by Thomas et al. 1 
The lymphocyte cultures were maintained as described. I Briefly,  10  s antigen reactive cells, 
10  ~ irradiated  syngeneic spleen  filler  cells,  and  105  irradiated  APC  in  1.5  ml  of medium 
supplemented with CAS were added to each well of Costar 24-well cluster trays (Costar 3524, 
Costar, Data Packaging, Cambridge, MA). Cells were recultured weekly after separation on 
Ficoll paque gradients (density 1.077; Pharmacia, Upsala, Sweden). Lymphocytes for interferon 
assays  were washed, separated on Ficoll paque gradients, washed again, and resuspended in 
medium as described above without CAS. 
The L cells used for interferon assays were originally obtained from Dr. M.-L. Lohmann- 
Matthes (Max Planck Institih f'fir Immunobiologie, Freiburg) and were cultured in RPMI 1640 
containing 7.5% heat-inactivated fetal calf serum. The overlay medium used for plaquing was 
minimal Eagle's medium diluted  1:1 with 1% agarose (Miles  Laboratories, South Africa). 
Interferon Induction and Assay.  Lymphocytes were distributed  at  10  s cells/well in  1.5 ml of 
medium  in Costar 24-well  dishes.  Irradiated APC were added  to each well  at  the required 
concentration, and the cultures were incubated at  37°C in a  humidified atmosphere of 10% 
CO2. Culture supernatants were usually harvested 48 h after the initial stimulation. 
Twofold dilutions  of the  supernatant  fluids  were  assayed  for interferon  by the  plaque- 
reduction method, essentially as described previously (8). 3 ×  105 mouse L cells were used for 
the assay, and Semliki Forest virus, which had been grown in L cells, was used as the indicator 
virus. Titers are expressed  as the reciprocal of the dilution causing a  50% reduction  in the 
number of plaques compared to the control plates (PRDs0). An internal standard was included 
in each assay. All samples from each experiment were assayed simultaneously. 
Results 
The  challenge  of sensitized  lymphocytes  with  specific  antigen  may  invoke  the 
production of several  lymphokines, including 7, interferon  (immune,  type II), (3-5). 
We  have  identified  a  product  demonstrating  antiviral  activity  from  the  culture 
supernatants  of oxazolone-specific continuous T  cell lines. The antiviral  activity was 
characterized as IFN-), because it was species specific, stable at 56°C for 30 min, and 
totally inactivated by treatment at pH 2 and by treatment with  100/tg/ml of trypsin 
(3, 6). 
Antigen  Specificity  and  Dose-Response  of IFN-'y  Induction.  The  titers  of  interferon 
produced when the 010  (CBA anti-oxazolone)  and 05  (BALB/c anti-oxazolone)  cell 
lines were stimulated  with different numbers of APC are shown in Tables I  and II, 
respectively.  Both  cell  lines  produced  higher  titers  of IFN-y when  stimulated  with 
increasing  numbers  of oxazolone-specific  APC.  A  minimum  of 2  ×  104  APC  was 
required  for induction  of detectable  IFN-y. Optimal  induction  occurred  when  the 
ratio of APC to oxazolone-specific lymphocytes was > 10:1. Oxazolone-specific induc- 
tion of IFN-7 was demonstrated  for both lines,  because neither  normal  lymph node 
ceils  nor  cells  presenting  an  unrelated  antigen,  e.g.,  picryt  chloride,  could  induce 
detectable levels of IFN-7,. A  decrease in interferon yield was also observed when the 
dose response experiment  was repeated with the addition of irrelevant  APC to keep 
the total number of APC constant  (Table I, experiment  2). 
MHC  Restriction  of IFN-  7  Induction.  We  used  several  inbred  strains  of mice  to 
determine whether antigen presentation  was MHC-restricted  (Table III). There was 
no response by either  line  to allogeneic  APC.  When the 010  line  (CBA,  H-2  k)  was 
stimulated with congenic BALB/c H-2  k cells, induction occurred, demonstrating that 
the oxazolone response was H-2  k restricted.  Further, because induction occurred with 1206  MeKIMM-BRESCHKIN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Antigen Specificity of Interferon Induction by the 010 hne 
(CBA-Anti-Oxazolone) 
Number of  Syngeneic APC  Number  IFN titer 
010 cells  PRD~0 
Experiment  1 
10  s  Oxazolone  i06  200 
105  Oxazolone  3 ×  105  100 
10  s  Oxazolone  105  2(1 
10  ~  Oxazolone  3 ×  105  5 
105  Picry[ chloride  105  <5 
lO  s  Normal  5 ×  105  <5 
0  Oxazolone  5 ×  105  <5 
Experiment 2 
105  Oxazolone:picryl chloride  5 ×  105:0  30 
10  ~  Oxazolone:picryl chloride  2 ×  105:3 ×  105  20 
105  Oxazolone:picryl chloride  1 ×  105:4 ×  I05  5 
105  Oxazolone:picryl chloride  0.5 ×  105:4.5  ×  105  <5 
TABLE  II 
Antigen Specificity of Interferon Induction by the 05 Line 
(BALB/c Anti-Oxazolone) 
Number of  Syngeneic APC  Number  IFN titer 
05 ceils  (PRD~0) 
105  Oxazolone  1 ×  10  ~  50 
105  Oxazolone  5 ×  104  20 
105  Oxazolone  2.5 ×  104  10 
l0  s  Oxazolone  1.25 X  104  <5 
105  Picryl chloride  1 ×  l0  s  <5 
t0  s  Normal  1 ×  105  <5 
0  Oxazo[one  1 ×  105  <5 
TABLE  III 
MHC Restriction of Interferon Induction by 05 and 010 Lines 
Source of APC 
IFN titer (PRDso) 
05  010 
CBA  <5  200 
BALB/c  20  <5 
BALB/c-H-2  k  <5  200 
CBA X BALB/c  50  100 
A.TL  <5  200 
105 antigen reactive cells were stimulated by 3 X  10  ~ APC. Supernatants were harvested 
after 48 h  for IFN assay. 
A.TL APC which are only matched at the major histocompatibility complex (MHC) 
I  region, the response to oxazolone must be I region restricted.  A  similar restriction 
was shown for the 05  BALB/c H-2  d, where induction  only occurred with syngeneic 
and (CBA ×  BALB/c)Fa APC. 
Kinetics oflFN- T Production.  The kinetics of IFN-y production by the 010 line are 
shown in Fig.  1. Culture supernatants were harvested at the indicated  time intervals 
and assayed for IFN activity. IFN-y was first detected 6-12  h  after stimulation and 
reached maximum levels by 30 h. Once this level was reached the IFN titer remained 
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FIG.  l.  Kinetics of IFN-y production by  10  ~ 010 cells stimulated with 3  ×  10  ~ oxazolone APC. 
O, cumulative interferon titers; WA, titers for consecutive intervals. 
To determine whether the IFN-~, was stable, or whether it was continually being 
degraded  and  newly  synthesized,  IFN-y  production  was  measured  between  time 
points. Supernatants from several cultures were removed every 6 h and replaced with 
fresh medium. IFN titers were then determined for consecutive time intervals (Fig.  1). 
Results  showed  that  even  in  the  presence  of continued  antigenic  stimulation,  no 
further IFN-y was produced after 36 h of stimulation. The IFN-y released before this 
time was stable to incubation at 37°C. 
Discussion 
Mitogen stimulation of IFN-y production by T  cell lines  (2)  and T  cell clones  (1) 
has  recently  been  reported.  We  were  therefore  interested  in  investigating  IFN-y 
production  by  T  cell  lines  and  clones  after  antigenic  stimulation.  We  have  two 
oxazolone-specific T  cell lines that have been passaged in tissue culture for at least 6 
1 
mo. 
After stimulation with specific APC, yields of IFN-y of 200 U/ml (or 300 U/culture 
well) were obtained from as few as  105 oxazolone-specifie T  lymphocytes. The levels 
of IFN-'), produced  were  dependent  upon  the  amount  of antigenic  stimulation.  A 
minimum  of 2  ×  104  oxazolone  APC  was  required  for  stimulation  of detectable 
IFN-  3,  production.  Optimal  induction  of  IFN-y  was  achieved  by  increasing  the 
numbers of APC to  106. The T  cell lines did not produce IFN-y when normal lymph 
node cells, or lymph node cells presenting the unrelated antigen picryl chloride, were 
added  to  the cultures.  The IFN was not  produced  by the APC  in  response to any 
factor  released  from  the  T  cells.  When  irrelevant  APC  were  added  to  maintain 
constant  APC  numbers,  the titer of IFN again decreased in response to decreasing 
oxazolone  APC.  Confirmation  of the  cellular  origin  of the  IFN  was  obtained  by 
treatment of the cells for 2 h with 0.5/zg/ml of emetine hydrochloride, an inhibitor of 
protein synthesis. The drug inhibited production of IFN only when the T  lymphocytes 
were treated (data not shown). 
Kinetics of IFN-y production demonstrated that maximal titers were obtained by 
1-2  d  after initial  stimulation.  Once  produced,  this  IFN-y was  stable  at  37°C  in 1208  McKIMM-BRESCHKIN  ET  AL.  BRIEF  DEFINITIVE  REPORT 
cultures for at least a further 3 d. No further de novo synthesis of IFN-y occurred after 
the first 36 h. These kinetics differed from those reported for mitogen stimulated IFN- 
y production, where maximal titers were reached 3-4 d  after stimulation (2, 7). Our 
kinetics more closely resembled those shown for induction of IFN-y by monoclonal 
antibodies recognizing T  cell antigens (7). 
IFN is known to be a  potent regulator of the immune system (9)  including DTH 
(10). The timing of IFN administration relative to antigen is crucial. Administration 
before antigen can decrease or totally inhibit the sensitization. IFN given at the same 
time or after antigen has no effect or even enhances DTH (10). Because IFN-~, was 
not  produced by  the  lines  until  6-12  h  after antigenic  stimulation  in  vitro,  IFN 
production in vivo would coincide with onset of DTH and may even enhance the 
response. 
IFN-y production was MHC restricted, and the response was controlled at least by 
the I region. DTH to protein antigens has been shown to be I region restricted (11- 
13). There is also a strong correlation between the Lyt-1 helper/DTH subset ofT cells 
(12,  13)  and  I  region  restriction,  as  opposed  to  K,D  restriction  of the  Lyt-l-2  + 
cytotoxic/suppressor subset. Because these oxazolone-specific T  cell lines produced an 
I-restricted DTH in vivo  1 and IFN-y induction in vitro was I region restricted, these 
may be functions of the same cell. Preliminary work with clones from these T  cell 
lines supports this.  Some clones demonstrated antigen-specific induction of IFN-y. 
Screening of clones by this assay also correlated extremely well with the results from 
DTH assays in vivo. Clones that  lost the ability to produce IFN-y in  response to 
antigenic stimulation also failed to elicit DTH in vivo. 
We  have  observed similar  antigen-specific induction  of IFN-y, not  only in  the 
oxazolone system, but  also  with  a  T  cell  line  reactive to  the  hapten  azobenzene 
arsonate. Thus antigen specific induction of IFN-y by continuous T cell lines provides 
a  useful  system  for studying  not  only  IFN-y  production,  but  for evaluating  the 
response to particular antigens. 
Summary 
Continuous cultures of T  cells reactive to the hapten 4-ethoxymethylene-2-phenyl- 
oxazolone were tested for interferon production after antigenic stimulation in vitro. 
Induction of interferon was antigen-specific and also restricted by the I region of the 
major histocompatibility complex. Kinetics of antigen induced interferon production 
were different from those reported for mitogen induced synthesis. 
Received  for publication 15 December 1981. 
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